Go Pro

Heartflow (NASDAQ:HTFL) CFO Vikram Verghese Sells 16,766 Shares of Stock

Heartflow logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Heartflow CFO Vikram Verghese sold 16,766 shares at an average price of $50.75, generating approximately $850,875. The sale, made under a pre-arranged Rule 10b5-1 plan, reduced his ownership by 9.75% to 155,183 shares.
  • Verghese has conducted several additional sales since September 2, selling more than 82,000 shares in total during the period described.
  • Heartflow shares recently traded at $50.75, near their 52-week high of $52.22. The company beat quarterly EPS estimates and reported 47.7% year-over-year revenue growth, while analysts maintained a “Moderate Buy” consensus with an average price target of $44.88.
  • Five stocks to consider instead of Heartflow.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 16,766 shares of the company's stock in a transaction on Friday, September 18th. The shares were sold at an average price of $50.75, for a total value of $850,874.50. Following the completion of the sale, the chief financial officer owned 155,183 shares in the company, valued at $7,875,537.25. This trade represents a 9.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

  • On Thursday, September 17th, Vikram Verghese sold 7,579 shares of Heartflow stock. The shares were sold at an average price of $50.11, for a total value of $379,783.69.
  • On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The shares were sold at an average price of $50.01, for a total transaction of $33,406.68.
  • On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
  • On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84.
  • On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total transaction of $332,199.20.
  • On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total transaction of $1,368,462.60.
  • On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Performance

Shares of NASDAQ:HTFL traded up $1.18 during trading on Friday, reaching $50.75. The stock had a trading volume of 6,606,910 shares, compared to its average volume of 1,824,326. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $52.22. The business's 50-day moving average price is $37.75 and its 200 day moving average price is $31.70.

Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million for the quarter. The business's revenue was up 47.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Hedge Funds Weigh In On Heartflow

Several hedge funds have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC acquired a new stake in Heartflow in the second quarter worth about $53,000. Essential Partners LLC acquired a new position in Heartflow during the 1st quarter valued at about $57,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Heartflow in the 4th quarter valued at about $72,000. Strs Ohio grew its position in shares of Heartflow by 35.3% during the 1st quarter. Strs Ohio now owns 4,600 shares of the company's stock worth $112,000 after buying an additional 1,200 shares during the period. Finally, Bessemer Group Inc. bought a new stake in shares of Heartflow during the first quarter worth approximately $126,000.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Morgan Stanley lifted their price target on Heartflow from $35.00 to $40.00 and gave the company an "equal weight" rating in a report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Wells Fargo & Company boosted their target price on shares of Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. UBS Group started coverage on shares of Heartflow in a research report on Wednesday, September 9th. They set a "neutral" rating and a $55.00 target price on the stock. Finally, Freedom Capital raised shares of Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Heartflow presently has an average rating of "Moderate Buy" and an average price target of $44.88.

Check Out Our Latest Analysis on HTFL

Heartflow Company Profile

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFRCT).

See Also

Insider Buying and Selling by Quarter for Heartflow (NASDAQ:HTFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Heartflow Right Now?

Before you consider Heartflow, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.

While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines